Centenial Surgical Suture Ltd (531380)
சுருக்கம்
The board meets on 12 Nov 2026 to consider the Q2 FY27 results.
நிகழ்வுகள்
- அடுத்த முடிவுகள்
- 12 நவ. 2026 (Q2 FY27)
- சமீபத்திய முடிவுகள்
- Q1 FY27, தாக்கல் செய்யப்பட்டது 15 ஆக. 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 5 நவ. 2026
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
Q2 FY27 முடிவுகள்
📅 அடுத்த நிதி முடிவுகள்: 12 நவ. 2026 (இயக்குநர் குழுக் கூட்டம்)Centenial Surgical Suture Ltd-இன் இயக்குநர் குழுக் கூட்டம் 12 நவ. 2026 அன்று நடைபெறுகிறது; அதில் அதன் Q2 FY27 முடிவுகள் பரிசீலிக்கப்படும் (ஜூலை-செப்டம்பர் 2026).
In its latest reported quarter, Q1 FY27, Centenial Surgical's revenue was ₹15.3 Cr (+18.6% year on year, +22.0% on the previous quarter), and net profit ₹0.7 Cr (against a loss a year earlier); the operating margin was 14.2%.
| Q1 FY27 (₹ கோடி) | மதிப்பு | YoY Q1 FY26-உடன் | QoQ |
|---|---|---|---|
| வருவாய் | ₹15.3 | +18.6% | +22.0% |
| செயல்பாட்டு லாபம் | ₹2.2 | +77.3% | +134.5% |
| நிகர லாபம் | ₹0.7 | நஷ்டத்திலிருந்து | நஷ்டத்திலிருந்து |
| EPS (₹) | 2.01 | நஷ்டத்திலிருந்து | நஷ்டத்திலிருந்து |
| செயல்பாட்டு லாப வரம்பு | 14.2% | — | — |
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
Centenial Surgical Suture Ltd has scheduled a Board of Directors meeting on November 12, 2026. The board will consider and approve standalone un-audited financial results for the quarter and half-year ended September 30, 2026. Additionally, the company will evaluate a proposal for raising funds through equity or other securities via rights issue, preferential issue, QIP, or other modes. The trading window remains closed from October 1, 2026, until November 14, 2026.
- Board meeting scheduled for November 12, 2026
- Approval of standalone un-audited results for Q2 and H1 ended September 30, 2026
- Consideration of fundraising proposals via rights issue, preferential issue, QIP, or other securities
- Trading window closed from October 1, 2026, through November 14, 2026
Centenial Surgical Suture Ltd has formally requested BSE and SEBI to urgently investigate suspected price manipulation and synchronized trading in its scrip (531380). The company noted micro-lot trades on October 26, 2026, including trades of just 2 shares at Rs 66.60 and 120 shares at Rs 71.25, driving abnormal price movements without underlying fundamental changes. The management reiterated that neither the company, promoters, nor directors are involved in these trading patterns and submitted transaction data from October 16 to October 23, 2026 for surveillance review.
- Company flagged morning trades on October 26, 2026, comprising 2 shares at Rs 66.60, 18 shares at Rs 66.60, 120 shares at Rs 71.25, and 2 shares at Rs 71.25
- Formal letters submitted to BSE Surveillance and SEBI requesting an investigation into alleged synchronized, circular trading across small retail lots
- Company explicitly stated it made no material business announcements to explain the recent sharp price movements
- Annexure submitted detailing investor trade data from October 16, 2026 to October 23, 2026
Centenial Surgical Suture Ltd has submitted a formal complaint to BSE Limited and SEBI requesting an urgent surveillance investigation into suspected manipulation of its stock. The company highlighted abnormal trading activity, noting that on the morning of October 21, 2026, only 1 equity share was traded at Rs 71.25. Management stated that buyers appear to be placing small, fragmented trades (1, 2, 3, 5, 10, or 20 shares) to artificially influence the price without any corporate announcements. The company clarified that neither it nor its promoters or directors are involved in these trading patterns.
- Company flagged that on October 21, 2026, only 1 equity share traded at Rs 71.25 in morning trading.
- Reported small fragmented buying patterns of 1, 2, 3, 5, 10, and 20 shares suspected of manipulating scrip pricing.
- Formally requested investigation and penal action by the Surveillance Departments of BSE and SEBI.
- Company affirmed zero involvement by promoters, directors, or management in the alleged trading syndicate.
Centenial Surgical Suture Ltd has submitted a formal surveillance complaint to BSE, flagging suspected market manipulation and unusual trades in its stock. The company highlighted that on October 19, 2026, the share price traded down to ₹71.25 on an executed volume of just 1 equity share in the morning session. It stated that these abnormal price movements are not supported by any corporate announcements or operational changes. Attached transaction records spanning August to October 2026 detail micro-lot transactions by various individual and corporate accounts.
- Company flagged unusual trade executed at ₹71.25 involving just 1 equity share on October 19, 2026
- Management submitted detailed individual transaction logs across August 21, 2026 to October 16, 2026
- Company formally requested BSE surveillance department intervention regarding suspected manipulative trading
Centenial Surgical Suture Ltd announced that Executive Director Anuradha Kashikar has resigned from her role effective October 5, 2026. The departure is attributed to personal reasons, with confirmation that there are no other material reasons. The micro-cap surgical equipment maker (market cap Rs 35 Cr, TTM revenue Rs 56 Cr) delivered a net profit of Rs 0.74 Cr in Q1 FY27 (ended June 2026) following a loss of Rs 2.21 Cr in FY26. Management has not yet announced a successor for the executive board role.
- Executive Director Anuradha Kashikar (DIN: 00804831) resigned effective October 5, 2026
- Resignation cited personal reasons with no other material reasons stated
- Company reported Rs 15.34 Cr in revenue for the recent June 2026 quarter against Rs 35 Cr market cap
Centenial Surgical Suture Ltd has formally approached the surveillance departments of BSE and SEBI, requesting an urgent investigation into abnormal price movements and suspected scrip manipulation. The company highlighted that single-share trades have repeatedly triggered 4.64% to 4.99% upper circuit moves on days including August 18, 21, and 26, 2026, despite no material business developments. Management explicitly clarified that the company, promoters, and directors have no involvement in these trades and submitted trading logs alleging synchronized nationwide buying.
- On August 26, 2026, a 1-share trade moved the price up 4.64% to Rs 97.49.
- On August 21, 2026, a 1-share trade increased the price by 4.99% to Rs 98.69.
- On August 18, 2026, a single-share trade drove the share price to Rs 90.00.
- Company submitted investor trading logs from December 2025 to February 2026 to substantiate claims of coordinated trading.
Centenial Surgical Suture Ltd has scheduled its 31st Annual General Meeting (AGM) for Monday, September 28, 2026, at 2:00 PM IST via Video Conferencing / Other Audio-Visual Means. The company has fixed Monday, September 21, 2026, as the cut-off date to determine shareholder eligibility for voting. Remote e-voting will commence on September 24, 2026, at 9:00 AM IST and conclude on September 27, 2026, at 5:00 PM IST. This is a standard corporate compliance announcement with no material financial impact.
- 31st AGM scheduled for Monday, September 28, 2026 at 02:00 p.m. IST via Video Conferencing.
- Cut-off date for e-voting eligibility fixed as Monday, September 21, 2026.
- Remote e-voting opens on Thursday, September 24, 2026 at 9:00 a.m. IST.
- Remote e-voting closes on Sunday, September 27, 2026 at 5:00 p.m. IST.
Centenial Surgical Suture Ltd has announced the closure of its Share Transfer Books and Register of Members from September 22, 2026 to September 28, 2026 (both days inclusive). The book closure is scheduled in preparation for its 31st Annual General Meeting (e-AGM) to be held on September 28, 2026. The micro-cap company (market cap ₹31 Cr) generated ₹53.84 Cr revenue and a net loss of ₹2.2 Cr in FY26. This filing is purely a routine statutory compliance under SEBI LODR Regulation 42.
- 31st Annual General Meeting (e-AGM) scheduled for September 28, 2026
- Book closure from September 22, 2026 to September 28, 2026 (both days inclusive)
- Board approval for the book closure granted on August 14, 2026
Centenial Surgical Suture Ltd announced the appointment of M/s. Utsav Shah & Associates, Chartered Accountants (FRN 140896W), as the Internal Auditor of the company for FY 2026-2027. The decision was approved by the Audit Committee and Board of Directors during their meeting on August 14, 2026. The lead auditor brings approximately a decade of experience in auditing and assurance services. This constitutes standard statutory and regulatory compliance under the Companies Act, 2013, with no material financial impact.
- Appointed M/s. Utsav Shah & Associates (FRN: 140896W) as Internal Auditor for FY 2026-2027
- Board meeting approving the appointment concluded on August 14, 2026 (05:00 PM to 05:30 PM)
- Lead auditor Shri Utsav Shah brings approximately 10 years of experience in auditing and assurance
Centenial Surgical Suture Ltd has announced key managerial changes effective August 14, 2026. Anuradha Kashikar, spouse of Managing Director Vijay Majrekar, has resigned from the position of Chief Financial Officer citing personal reasons. The Board has appointed Ms. Sapna Mhatre, who has been with the company since September 2001 as Chief Administrative Officer, as the new CFO. The micro-cap company currently operates with a market cap of ₹31 Cr and TTM revenue of ₹56 Cr.
- Anuradha Kashikar resigned as CFO and KMP effective August 14, 2026, citing personal reasons.
- Sapna Mhatre appointed as Chief Financial Officer and KMP effective August 14, 2026.
- Incoming CFO Sapna Mhatre has been in employment with the company since September 2001.
- Outgoing CFO is the spouse of MD Vijay Majrekar; incoming CFO is confirmed unrelated to any director.
Centenial Surgical Suture reported standalone revenue of ₹15.34 cr for the quarter ended June 30, 2026, up 18.6% YoY from ₹12.94 cr in the year-ago period. Operating profit stood at ₹2.18 cr, a substantial improvement from ₹0.93 cr in the previous quarter. The company turned profitable with a net profit of ₹0.74 cr (EPS ₹2.01) compared to a net loss of ₹2.31 cr in Mar 2026 and ₹0.04 cr in Jun 2025.
- Revenue from operations increased 18.6% YoY to ₹15.34 cr (vs ₹12.94 cr in Jun 2025)
- Operating profit expanded to ₹2.18 cr from ₹1.23 cr in Jun 2025 and ₹0.93 cr in Mar 2026
- Net profit swung to ₹0.74 cr versus a loss of ₹2.31 cr in Mar 2026 and loss of ₹0.04 cr in Jun 2025
- Diluted/Basic EPS for the quarter improved to ₹2.01
Centenial Surgical Suture has scheduled a board meeting on August 14, 2026, to approve standalone financial results for the quarter ended June 30, 2026. The board will also consider the re-appointment of Ms. Anuradha Kashikar as Executive Director for a three-year term and appoint M/s. Utsav Shah & Associates as Internal Auditors for FY27. This follows a weak FY26 where the company reported a net loss of ‡2.2 crore on ‡53.84 crore revenue. Investors will be looking for signs of recovery after the significant ‡2.31 crore loss reported in the March 2026 quarter.
- Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results.
- Proposed re-appointment of Ms. Anuradha Kashikar as Executive Director for a period of 3 years.
- Appointment of M/s. Utsav Shah & Associates as Internal Auditors for the 2026-2027 financial year.
- Trading window for company securities remains closed from July 1, 2026, until August 16, 2026.
- Company to fix dates for the 31st Annual General Meeting (AGM) during this meeting.
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
